Skip to main content
Journal cover image

A rationale for conducting parallel mechanistic studies in clinical trials of pharmacotherapy.

Publication ,  Journal Article
Becker, RC
Published in: Journal of thrombosis and thrombolysis
June 2008

Duke Scholars

Published In

Journal of thrombosis and thrombolysis

DOI

EISSN

1573-742X

ISSN

0929-5305

Publication Date

June 2008

Volume

25

Issue

3

Start / End Page

300 / 302

Related Subject Headings

  • Treatment Outcome
  • Research Design
  • Pharmacogenetics
  • Patient Selection
  • Molecular Diagnostic Techniques
  • Humans
  • Drug-Related Side Effects and Adverse Reactions
  • Drug Industry
  • Clinical Trials as Topic
  • Cardiovascular System & Hematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Becker, R. C. (2008). A rationale for conducting parallel mechanistic studies in clinical trials of pharmacotherapy. Journal of Thrombosis and Thrombolysis, 25(3), 300–302. https://doi.org/10.1007/s11239-008-0231-0
Becker, Richard C. “A rationale for conducting parallel mechanistic studies in clinical trials of pharmacotherapy.Journal of Thrombosis and Thrombolysis 25, no. 3 (June 2008): 300–302. https://doi.org/10.1007/s11239-008-0231-0.
Becker RC. A rationale for conducting parallel mechanistic studies in clinical trials of pharmacotherapy. Journal of thrombosis and thrombolysis. 2008 Jun;25(3):300–2.
Becker, Richard C. “A rationale for conducting parallel mechanistic studies in clinical trials of pharmacotherapy.Journal of Thrombosis and Thrombolysis, vol. 25, no. 3, June 2008, pp. 300–02. Epmc, doi:10.1007/s11239-008-0231-0.
Becker RC. A rationale for conducting parallel mechanistic studies in clinical trials of pharmacotherapy. Journal of thrombosis and thrombolysis. 2008 Jun;25(3):300–302.
Journal cover image

Published In

Journal of thrombosis and thrombolysis

DOI

EISSN

1573-742X

ISSN

0929-5305

Publication Date

June 2008

Volume

25

Issue

3

Start / End Page

300 / 302

Related Subject Headings

  • Treatment Outcome
  • Research Design
  • Pharmacogenetics
  • Patient Selection
  • Molecular Diagnostic Techniques
  • Humans
  • Drug-Related Side Effects and Adverse Reactions
  • Drug Industry
  • Clinical Trials as Topic
  • Cardiovascular System & Hematology